Anand Tharmaratnam

Dr. Tharmaratnam has over 23 years of experience in global drug development and the CRO industry. He was previously President Asia Pacific at IQVIA, a global provider of advanced analytics, technology solutions and clinical research services.

In his prior roles, Dr Tharmaratnam led over 15,000 employees in clinical development and market access across 13 Asia Pacific countries, and helped build the first billion-dollar CRO business in the Asia Pacific. A medical doctor by training, Dr Tharmaratnam graduated from University College London, UK and trained in Anaesthesia and Critical Care.